Cytochrome P450 2J3/epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 1, 2011, Pages 63-70

  Yu, Gang Gang ^a   Zeng, Xiang Jun ^a   Wang, Hong Xia ^a   Lu, Ling Qiao ^a   Zheng, Shao Peng ^b   Ma, Li Quan ^c   Chang, Jing ^a   Wang, Jing ^a   Zhang, Dong Mei ^a   Du, Feng He ^c   Zhang, Li Ke ^a  

^a Departments of Pathophysiology   (China)

^b Biochemistry and Molecular Biology   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cytochrome P450; Ischaemia reperfusion; Post conditioning; Preconditioning

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; CYTOCHROME P450 2J3; CYTOCHROME P450 INHIBITOR; EPOXYICOSATRIENOIC ACID; N METHYLSULFONYL 6 (2 PROPARGYLOXYPHENYL)HEXANAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; CYTOCHROME P-450 ENZYME SYSTEM; CYTOPROTECTION; HEART; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MODELS, BIOLOGICAL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 78650668373     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05464.x     Document Type: Article

References (34)

1. Iliodromitis EK, Georgiadis M, Cohen MV, Downey JM, Bofilis E, Kremastinos DT. Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res. Cardiol. 2006; 101: 502-7.
2. Kin H, Zhao ZQ, Sun HY et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc. Res. 2004; 62: 74-85.
3. + channels and p42/p44 MAPK pathway. Circ. Res. 2004; 95: 506-14.
4. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 2004; 44: 1103-10.
5. Zhao ZQ, Corvera JS, Halkos ME et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 2003; 285: H579-88.
6. Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc. Res. 2006; 70: 297-307.
7. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol. Rev. 2007; 59: 418-58.
8. Kin H, Zatta AJ, Lofye MT et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc. Res. 2005; 67: 124-33.
9. + channel and protein kinase C activation. Basic Res. Cardiol. 2006; 101: 180-9.
10. Zatta AJ, Kin H, Lee G et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc. Res. 2006; 70: 315-24.
11. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway. A common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 2005; 15: 69-75.
12. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning. A form of 'modified reperfusion' protects the myocardium by activating the phosphatidylinositol 3-kinase - Akt pathway. Circ. Res. 2004; 95: 230-2.
13. Jenkins CM, Cedars A, Gross RW. Eicosanoid signalling pathways in the heart. Cardiovasc. Res. 2009; 82: 240-9.
14. Wu S, Chen W, Murphy E et al. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J. Biol. Chem. 1997; 272: 12551-9.
15. Nithipatikom K, Moore JM, Isbell MA, Falck JR, Gross GJ. Epoxyeicosatrienoic acids in cardioprotection: Ischemic versus reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2006; 291: H537-42.
16. Ma LQ, Wang HX, You HJ et al. Ischemic postconditioning alleviates myocardial ischemia/reperfusion injury in rats in vitro. Basic Clin. Med. 2007; 27: 260-2. (in Chinese)
17. Yue H, Strauss KI, Borenstein MR, Barbe MF, Rossi LJ, Jansen SA. Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2004; 803: 267-77.
18. Sato H, Bolli R, Rokosh GD et al. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am. J. Physiol. Heart Circ. Physiol. 2007; 293: H2557-64.
19. Argaud L, Gateau-Roesch O, Augeul L et al. Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H386-91.
20. Seubert JM, Sinal CJ, Graves J et al. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ. Res. 2006; 99: 442-50.
21. Motoki A, Merkel MJ, Packwood WH et al. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. Am. J. Physiol. Heart Circ. Physiol. 2008; 295: H2128-34.
22. Wang YX, Lu LQ, Wang XY et al. Protective effects of 11, 12-epoxyeicosatrienoic acid preconditioning and postconditioning on myocardial ischemia/reperfusion injury in rats. Sheng Li Xue Bao 2008; 60: 23-8. (in Chinese)
23. Michaelis UR, Xia N, Barbosa-Sicard E, Falck JR, Fleming I. Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2008; 49: 1242-7.
24. 2+ entry in porcine aortic endothelial cells. Br. J. Pharmacol. 1997; 121: 1579-88.
25. Gross GJ, Gauthier KM, Moore J, Campbell WB, Falck JR, Nithipatikom K. Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog. Am. J. Physiol. Heart Circ. Physiol. 2009; 297: H47-52.
26. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 1999; 341: 233-49.
27. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion: A target for cardioprotection. Cardiovasc. Res. 2004; 61: 372-85.
28. Halestrap AP. What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 2009; 46: 821-31.
29. Dhanasekaran A, Gruenloh SK, Buonaccorsi JN et al. Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H724-35.
30. Bodiga S, Zhang R, Jacobs DE et al. Protective actions of epoxyeicosatrienoic acid: Dual targeting of cardiovascular PI3K and K(ATP) channels. J. Mol. Cell. Cardiol. 2009; 46: 978-88.
31. Batchu SN, Law E, Brocks DR, Falck JR, Seubert JM. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J. Mol. Cell. Cardiol. 2009; 46: 67-74.
32. Wang H, Lin L, Jiang J et al. Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J. Pharmacol. Exp. Ther. 2003; 307: 753-64.
33. Katragadda D, Batchu SN, Cho WJ, Chaudhary KR, Falck JR, Seubert JM. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells. J. Mol. Cell. Cardiol. 2009; 46: 867-75.
34. Gross GJ, Hsu A, Falck JR, Nithipatikom K. Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. J. Mol. Cell. Cardiol. 2007; 42: 687-91.